Last reviewed · How we verify
CTO0303-A
At a glance
| Generic name | CTO0303-A |
|---|---|
| Sponsor | Taejoon Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Comparing Efficacy and Safety of CTO0303 in Pediatric Subjects (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |